MedPath

Evaluation of Legionella PCR Techniques for the Routine Diagnosis of Legionellosis

Not Applicable
Terminated
Conditions
Legionellosis
Interventions
Procedure: Characterization Legionnella
Registration Number
NCT00452153
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

The validity of molecular techniques for the diagnosis of legionellosis is not known. Although PCR can detect Legionella pneumophila (responsible for 80% of legionellosis) and other Legionella species, this test is not recommended in standard guidelines to assess this diagnostic, by contrast to culture of sputum, serology and urine antigen. The aim of this study is to evaluate Legionella PCR techniques, performed directly onto the sputum aspirates, for the routine diagnosis of pneumonia in adults' patients admitted to hospital. This study implicates 3 University hospitals (Lyon, Grenoble and Saint-Etienne) in collaboration with the French reference center of legionellosis for a previous duration of one year. In addition to the usual diagnostic tests that are performed when pneumonia is suspected, real-time PCR will be added for the detection and differentiation of Legionella. Hypothesizing the inclusion of 1000 pneumonia in this study, the predictable number of newly-detected legionellosis will be approximately 60 to 70 cases. According to a predefined algorithm, cases of legionellosis will be classified as definite or probable. Sensitivity and specificity of the real-time PCR will be calculated according to this classification. This study is intended to validate real-time PCR as a tool for the rapid diagnosis of legionellosis, allowing to optimize the antibiotic treatment of pneumonia. PCR techniques can also contribute to the better detection and differentiation of Legionella sp infections that are not documented accurately by routine microbiologic tests.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Written informed consent
  • Patient affiliated to social insurance
  • Community acquired or nosocomial pneumonia
Exclusion Criteria
  • No sputum aspirate

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Characterization LegionnellaCharacterization LegionnellaCharacterization Legionnella by polymerase chain reaction (PCR)
Primary Outcome Measures
NameTimeMethod
Definite or probable legionellosisInclusion and J30
Secondary Outcome Measures
NameTimeMethod
Definite legionellosisInclusion and J30
Probable legionellosisInclusion and J30
Possible legionellosisInclusion and J30

Trial Locations

Locations (6)

HMU CHU Saint-Etienne

πŸ‡«πŸ‡·

Saint-etienne, France

Infectious Disease unit CHU de Saint-Etienne

πŸ‡«πŸ‡·

Saint-etienne, France

Reanimation unit - Hopital Bellevue - CHU de Saint-Etienne

πŸ‡«πŸ‡·

Saint-etienne, France

Pneumology unit CHU de Saint-Etienne

πŸ‡«πŸ‡·

Saint-etienne, France

Reanimation unit - HΓ΄pital NORD - CHU de Saint-Etienne

πŸ‡«πŸ‡·

Saint-etienne, France

Urgency unit CHU Saint-Etienne

πŸ‡«πŸ‡·

Saint-etienne, France

Β© Copyright 2025. All Rights Reserved by MedPath